Subcutaneous Injection

Definition

Subcutaneous (SubQ) injection is the administration of a compound into the fatty tissue layer between the skin and muscle. It is the most common route of administration for research peptides and many approved peptide therapeutics, offering reliable absorption with relatively simple technique.

Why SubQ for Peptides

Subcutaneous injection is preferred for peptides because:

• Avoids gastrointestinal degradation — Bypasses the proteolytic enzymes that destroy most peptides when taken orally
• Predictable absorption — Creates a local depot from which the peptide is gradually absorbed into systemic circulation
• Self-administration — Simpler and safer than intravenous or intramuscular injection for repeated dosing
• High bioavailability — Typically achieves 50–80% bioavailability depending on the peptide

Pharmacokinetics

SubQ injection produces slower absorption and lower peak concentrations compared to intravenous administration, but with a more sustained profile. Absorption rate depends on blood flow to the injection site, peptide molecular weight, formulation, and injection volume. Common injection sites include the abdomen, thigh, and upper arm.

Relevance to Peptide Research

The vast majority of research peptides — including GH secretagogues, BPC-157, TB-500, melanocortin agonists, and GLP-1 analogues — are administered subcutaneously in research protocols. Understanding SubQ pharmacokinetics is essential for interpreting study data, as absorption kinetics differ significantly from IV administration and influence peak levels, duration of action, and overall exposure.

Related Peptides

Peptide profiles that reference “Subcutaneous Injection” in their research content.